TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE).

Yuankai Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.